Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2011 Nov 1;58(3):261–268. doi: 10.1097/QAI.0b013e3182324af9

Table 1b.

Sustained virological response (SVR) stratified by fibrosis stage for the total study population.

Growth Factors Dose Reduction
Stage Total (N=45) SVR, N (%) Total (N=41) SVR, N (%)
0 0 0 2 1 (50)
1 14 3 (21.4) 10 1 (10)
2 14 2 (14.3) 18 5 (28)
3 11 4 (36.4) 2 0 (0)
4 6 2 (33.3) 9 1 (11)
Total 45 11 (24.4) 41 8 (19.5)